BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37916054)

  • 41. Reproductive and Obstetric Outcomes After Hysteroscopic Removal of Retained Products of Conception.
    van Wessel S; Coryn N; van Vliet H; Schoot B; Weyers S; Hamerlynck T
    J Minim Invasive Gynecol; 2020; 27(4):840-846. PubMed ID: 31352066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
    Tarasov M; Burke YZ; Stockheim D; Orvieto R; Cohen SB
    Arch Gynecol Obstet; 2020 Dec; 302(6):1523-1528. PubMed ID: 32785781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
    Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
    Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of clinical and ultrasound findings in the diagnosis of retained products of conception.
    Abbasi S; Jamal A; Eslamian L; Marsousi V
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):704-7. PubMed ID: 18792059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Office intrauterine morcellation for retained products of conception.
    Damiani GR; Di Gennaro D; Vimercati A; Cicinelli E; Perrone AM; De Iaco P; Malvasi A; Gaetani M; Cascardi E; Cazzato G; Dellino M; Pellegrino A; Vitagliano A
    Minim Invasive Ther Allied Technol; 2023 Dec; 32(6):323-328. PubMed ID: 37493491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expectant management of retained products of conception following abortion: A retrospective cohort study.
    Wada Y; Takahashi H; Suzuki H; Ohashi M; Ogoyama M; Nagayama S; Baba Y; Usui R; Suzuki T; Ohkuchi A; Fujiwara H
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():1-5. PubMed ID: 33689917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Operative hysteroscopy with the Bigatti shaver (IBS ®) for the removal of placental remnants.
    Ansari SH; Bigatti G; Aghssa MM
    Facts Views Vis Obgyn; 2018 Sep; 10(3):153-159. PubMed ID: 31191850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Conundrum: A 39-Year-Old With Chronic Retained Products of Conception and Concurrent Uterine Arteriovenous Malformation.
    Shivji A; Skolnik E; Dalton A; Nensi A; Shah R
    J Obstet Gynaecol Can; 2021 Jul; 43(7):864-868. PubMed ID: 34253305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum β-HCG Level in Women Diagnosed as Having Retained Products Of Conception: A Prospective Cohort Study.
    Smorgick N; Segal H; Eisenberg N; Dovev MN; Dvash S; Rabinovich I
    J Minim Invasive Gynecol; 2022 Mar; 29(3):424-428. PubMed ID: 34801711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Reproductive Outcomes following Retained Products of Conception after Vaginal Delivery versus First-Trimester Abortion.
    Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
    Gynecol Obstet Invest; 2015; 80(3):206-10. PubMed ID: 26088169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiologic, histologic, and imaging features of retained products of conception.
    Sellmyer MA; Desser TS; Maturen KE; Jeffrey RB; Kamaya A
    Radiographics; 2013 May; 33(3):781-96. PubMed ID: 23674774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; van Wessel S; Weyers S; Broekmans FJ; D'Hooghe TM; Bongers MY; Mol BWJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009461. PubMed ID: 30521679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Operative hysteroscopy for retained products of conception: Efficacy and subsequent fertility.
    Capmas P; Lobersztajn A; Duminil L; Barral T; Pourcelot AG; Fernandez H
    J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):151-154. PubMed ID: 30553048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical and Reproductive Outcomes after Hysteroscopic Removal of Retained Products of Conception: A Systematic Review and Meta-analysis.
    Vitale SG; Parry JP; Carugno J; Cholkeri-Singh A; Della Corte L; Cianci S; Schiattarella A; Riemma G; De Franciscis P
    J Minim Invasive Gynecol; 2021 Feb; 28(2):204-217. PubMed ID: 33166659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hysteroscopic resection with temporary balloon catheter occlusion of bilateral internal iliac arteries for managing retained products of conception after spontaneous abortion: Two cases report.
    Ono Y; Sakurai Y; Ota H; Tanaka K; Okada H; Tagaya H; Fukushi Y; Yoshino O; Wada S
    J Obstet Gynaecol Res; 2023 Feb; 49(2):753-758. PubMed ID: 36305385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications].
    Zeng WJ; An SL; Huang H; Huang QT; Li FF; Wang HZ; Cai DC; Gao YF
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):569-574. PubMed ID: 28539276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study.
    Wagenaar LP; van Vliet HA; Radder CM; Peters LW; Weyers S; Schoot BC; Hamerlynck TW
    Eur J Obstet Gynecol Reprod Biol X; 2023 Dec; 20():100230. PubMed ID: 37701632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study.
    Kobayashi M; Nakagawa S; Kawanishi Y; Masuda T; Maenaka T; Toda A; Miyake T; Hiramatsu K; Miyoshi A; Mimura K; Kimura T; Endo M; Kimura T
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):653. PubMed ID: 34560846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound features help identify patients who can undergo noninvasive management for suspected retained products of conception: a single institutional experience.
    Vyas S; Choi HH; Whetstone S; Jha P; Poder L; Shum DJ
    Abdom Radiol (NY); 2021 Jun; 46(6):2729-2739. PubMed ID: 33459841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
    Hershko Klement A; Frederic M; Bentov Y; Chang P; Nayot D; Haas J; Casper RF
    Gynecol Endocrinol; 2018 Jul; 34(7):609-611. PubMed ID: 29345165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.